|
|
The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy. |
Williford C
| |||
C5: Evolving Challenges for the Laboratory Diagnosis of Sexually Transmitted Diseases | |||
| Organizer: | John R. Papp | ||
| Moderator: | John R. Papp | ||
| Summary: | Background/Purpose: Technologic advances have spurred significant improvements for clinical laboratory services including greater flexibility in etiologic detection and result reporting. Clinical laboratories may develop tests for rapid detection of emergent pathogens or incorporate new test marketed for endemic pathogens. Despite this array, mutations in organisms may adversely affect detection. Objectives of Symposium: Highlight key developments do improve or hinder the laboratory diagnosis of sexually transmitted diseases. Implications for Programs, Policy, and/or Research: Providers and disease control officials would garner information on a wide variety of bacterial and viral sexually transmitted diseases. This will be particularly useful developing or augmenting existing disease control programs. |
||
| 10:15 AM | C5a | Implications of the variant strain of Chlamydia trachomatis (CT) circulating in Sweden Charlotte A. Gaydos | |
| 10:35 AM | C5b | Real-time PCR as a tool for surveillance for L-serovars of Chlamydia trachomatis (the cause of Lymphogranuloma Venereum) in San Francisco Mark Pandori | |
| 10:55 AM | C5c | Diagnosis of genital ulcer disease by PCR Chen Y. Cheng | |
| 11:15 AM | C5d | Detection of syphilis and HSV in MSM Anne Rompalo | |
| 11:35 AM | C5e | New Technologies in Cervical Cancer Screening Cosette Wheeler | |